[The effect of cytostatic and immunomodulator therapy on the morphology of the tumor and lymphoid organs and on the count of large granular lymphocytes in the blood of mice with Lewis carcinoma].
Potapov. Iu I IuI; Khaleev. D V DV; Krutova. T V TV; Pashkova. V S VS
Key Findings
- NMU directly damages tumors but also suppresses the host immune system
- Thymalin (and interferon) provide only a small recovery of immune cells after NMU treatment
- Methotrexate’s anti‑tumor effect may involve stimulating the immune system
Practical Outcomes
- For biohackers, thymalin alone is unlikely to offset immune suppression from strong chemotherapies. The modest immune benefit seen in mice doesn’t translate into a clear protocol for healthy people seeking longevity or performance gains. More human data are needed before considering thymalin for immune support in stressful or disease contexts.
Summary
In mice with lung cancer, a drug that directly attacks the tumor (NMU) also weakens the immune system, and adding the peptide thymalin (or interferon) only slightly helps the immune cells recover. Another drug, methotrexate, both kills tumor cells and seems to boost the immune response, which may help control the tumor. The study shows thymalin’s immune‑boosting effect is modest in this cancer setting.
Abstract
Effects of separate and combined therapy with nitrosomethylurea (NMU), methotrexate thymalin, and reaferon on tumor, thymus and spleen morphology as well as the content of large granular lymphocytes in blood were studied in mice with Lewis lung carcinoma. The study revealed different effects of methotrexate and NMU on tumor and lymphoid organs. The direct NMU damage to tumor was accompanied by a suppression of host immune system which was only slightly reversed with immunomodulators. The cytotoxic antitumor effect of methotrexate was probably related also with the stimulation of host immune system, its cells in turn affecting the size of proliferating tumor fraction.
Study Information
pubmed
1993